James H. Sabry

Member of the Enlarged Corporate Executive Committee, Global Head Pharma Partnering at Roche Holding AG

James H. Sabry

James H. Sabry

Member of the Enlarged Corporate Executive Committee, Global Head Pharma Partnering at Roche Holding AG

Overview

Career Highlights

Cytokinetics, Inc.
Arête Therapeutics, Inc.

RelSci Relationships

5379

Number of Boards

7

Birthday

12/1958

Age

62

Relationships

View Relationship Details

RelSci Relationships are individuals James H. Sabry likely has professional access to. A relationship does not necessarily indicate a personal connection.

Severin Schwan

Chief Executive Officer at Roche Holding AG

Relationship likelihood: Strong

Osamu Nagayama

Chairman & Chief Executive Officer of Chugai at Roche Holding AG

Relationship likelihood: Strong

Cristina A. Wilbur

Head-Group Human Resources at Roche Holding AG

Relationship likelihood: Strong

Robert I. Blum

Director, President & Chief Executive Officer at Cytokinetics, Inc.

Relationship likelihood: Strong

James Spudich

Relationship likelihood: Strong

Alan Hippe

Chief Financial & Information Technology Officer at Roche Holding AG

Relationship likelihood: Strong

Carole L. Nüchterlein

Chief Executive Officer at Roche Ventures

Relationship likelihood: Strong

Karl Mahler

Relationship likelihood: Strong

Per-Olof Attinger

Secretary-Executive Committee & Head-Chief Executive Officer Office at Roche Holding AG

Relationship likelihood: Strong

Gottlieb A. Keller

Vice Chairman at ScienceIndustries

Relationship likelihood: Strong

Reveal deeper insights into your organization's relationships
with RelSci Contact Aggregator.

Empower Your Business Applications with Industry-Leading
Relationship Data from the RelSci API.

Get Contact Information on the
World's Most Influential Decision Makers.

Discover the Power of Your Network with
RelSci Premium Products.

In The News

Business Wire

February 2, 2021

X-Chem Enters into Multitarget Oncology Discovery Research Collaboration and License Agreement with Genentech; Collaboration Includes Licensing of Preclinical Small Molecule Program

Business Wire

January 6, 2021

Ribometrix Announces Collaboration with Genentech to Discover and Develop RNA-Targeted Small Molecule Therapeutics

GlobeNewswire

December 14, 2020

Relay Therapeutics Announces a Worldwide License and Collaboration Agreement with Genentech for RLY-1971

PR Newswire

November 16, 2020

Lead Pharma enters into a Research Collaboration and License Agreement with Roche to Develop Oral Small Molecules for Immune Mediated Diseases; - R&D collaboration building on Lead Pharma's expertise in the discovery, design and optimization of small mole

ICT Monitor Worldwide

October 21, 2020

Genesis Therapeutics and Genentech Enter AI-Driven Drug Discovery Collaboration

Paths to James H. Sabry

Potential Connections via
Relationship Science

You

James H. Sabry

Member of the Enlarged Corporate Executive Committee, Global Head Pharma Partnering at Roche Holding AG

Education

MD

Queen’s University

Queen's University at Kingston (commonly shortened to Queen's University or Queen's) is a public research university located in Kingston, Ontario, Canada. Founded on 16 October 1841, the university predated the founding of Canada by 26 years. Queen's holds more than 1,400 hectares (3,500 acres) of land throughout Ontario and owns Herstmonceux Castle in East Sussex, England. Queen's is organized into ten undergraduate, graduate and professional faculties and schools. The Church of Scotland established Queen's College in 1841 with a royal charter from Queen Victoria. The first classes, intended to prepare students for the ministry, were held 7 March 1842 with 13 students and two professors. Queen's was the first university west of the maritime provinces to admit women, and to form a student government. In 1883, a women's college for medical education affiliated with Queen's University. In 1888, Queen's University began offering extension courses, becoming the first Canadian university to do so. In 1912, Queen's secularized and changed to its present legal name.

PhD in Cell Biology

University of California - San Francisco

The University of California, San Francisco (UCSF), is a center of health sciences research, patient care, and education; located in San Francisco, California. UCSF is widely regarded as one of the world's leading universities in health sciences. Though one of the 10 campuses of the University of California, it is unique for being the only University of California campus dedicated solely to graduate education, and in health and biomedical sciences. Some of UCSF's treatment centers include kidney transplants and liver transplantation, radiology, neurosurgery, neurology, oncology, ophthalmology, gene therapy, women's health, fetal surgery, pediatrics, and internal medicine.

Memberships

Member

Current

Young Presidents' Organization

YPO (Young Presidents’ Organization) connects people with successful young chief executives in a global network unlike any other. Founded in 1950 in New York City by a young president named Ray Hickok, the organization unites approximately 20,000 business leaders in more than 120 countries around a shared mission: Better Leaders Through Education and Idea Exchange. A great deal has changed since YPO’s founding but certain things have remained the same: the value of a peer network and trusted mentors, the importance of ongoing education, and the need for a “safe haven” where issues can be aired in an environment of confidentiality. Over the past six decades, YPO has maintained its core commitment to these ideals while embracing change with each successive generation of young business leaders.

Member

Current

American Society of Clinical Oncology

The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology.American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research.

Member

Current

The American Society for Cell Biology

ASCB IS AN INCLUSIVE, INTERNATIONAL COMMUNITY OF BIOLOGISTS STUDYING THE CELL, THE FUNDAMENTAL UNIT OF LIFE. WE ARE DEDICATED TO ADVANCING SCIENTIFIC DISCOVERY, ADVOCATING SOUND RESEARCH POLICIES, IMPROVING EDUCATION, PROMOTING PROFESSIONAL DEVELOPMENT, AND INCREASING DIVERSITY AND INCLUSIVITY IN THE SCIENTIFIC WORKFORCE.

Career History

Global Head of Partnering

2018 - Current

F. Hoffmann-La Roche Ltd.

F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

Member of the Enlarged Corporate Executive Committee, Global Head Pharma Partnering

Current

Roche Holding AG

Roche Holding ag Roche Personalised Healthcare – our mission The healthcare landscape is constantly changing. Patients, physicians and payers demand safer, more effective treatments, while investors search after robust and sustainable business models. Growing demand for highly effective, impactful medicines is being driven by an aging population, healthcare and economic pressures. But an influx of new technologies enables Roche to meet this need by offering innovative tests and medicines. These healthcare drivers have led us in one direction – ‘Roche Personalised Healthcare’. At Roche, ‘Personalised Healthcare’ is at the core of our business strategy

President & Chief Executive Officer, Director

1997 - 2010

Cytokinetics, Inc.

Cytokinetics, Inc. operates as a biopharmaceutical company, which focuses on the discovery and development of muscle activators as potential treatment for debilitating diseases. It conducts a Phase 2 clinical trials program for tirasemtiv, including a Phase 2b clinical trial in patients with ALS, known as BENEFIT-ALS (Blinded Evaluation of Neuromuscular Effects and Functional Improvement with Tirasemtiv in ALS). The company was founded on August 5, 1997 and is headquartered in South San Francisco, CA.

Boards & Committees

Member, Board of Directors

2019 - Current

Chugai Pharmaceutical Co., Ltd.

Chugai Pharmaceutical Co., Ltd. engages in the research, development, manufacturing, sale, importation, and exportation of pharmaceuticals. Its operations are carried out through the Domestic and Overseas businesses. The Domestic Business covers the manufacturing, research, and development operations in Japan. The Overseas business comprises of sales and production in Europe, Taiwan and China. The company was founded by Juzo Ueno on March 10, 1925 and is headquartered in Tokyo, Japan.

Member, Enlarged Corporate Executive Committee

2018 - Current

F. Hoffmann-La Roche Ltd.

F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

Member, Board of Directors

2015 - Current

California Biomedical Innovation Alliance

California Biomedical Innovation Alliance is an American private company located in South San Francisco, CA, with operations in the United States. The firm provides biomedical advocacy and community services. Sara Radcliffe is currently the CEO of the company.The company says this about itself: California Life Sciences Association (CLSA) is the state’s largest and most influential life sciences advocacy and business leadership organization. With offices in Sacramento, San Diego, South San Francisco, Los Angeles and Washington DC, CLSA works closely with industry, government, academia and others to shape public policy, improve access to innovative technologies and grow California’s life sciences economy. CLSA serves bio technology, pharmaceutical, medical device and diagnostics companies, research universities and institutes, investors and service providers throughout the Golden State. CLSA was founded in 2015 when the Bay Area Bioscience Association (BayBio) and the California Healthcare Institute (CHI) merged.

Board Member

2006 - ?

HopeLab Foundation, Inc.

HopeLab Foundation is a non-profit organization that develops technology-based products to improve human health and well-being. Its products include Mitra App, Greater Good in Action, Mood Meter App, Re-Mission 2, Zamzee, Resilience Initiative, Re-Mission, Ruckus Nation, and Digital Storytelling Workshop. The company was founded by Pam Omidyar in 2001 and is headquartered in Redwood City, CA.

Director

Tenure Unconfirmed

California Life Sciences Association

California Life Sciences Association is an American nonprofit company located in South San Francisco, CA, that acts as a trade association which represents the life sciences industry of California. Mike Guerra is the current CEO, occupying that position since 2019.The company says this about itself: California Life Sciences Association (CLSA) is the state’s largest and most influential life sciences advocacy and business leadership organization. With offices in Sacramento, San Diego, South San Francisco, Los Angeles and Washington DC, CLSA works closely with industry, government, academia and others to shape public policy, improve access to innovative technologies and grow California’s life sciences economy. CLSA serves biotechnology, pharmaceutical, medical device and diagnostics companies, research universities and institutes, investors and service providers throughout the Golden State.

Director

Tenure Unconfirmed

The American Society for Cell Biology

ASCB IS AN INCLUSIVE, INTERNATIONAL COMMUNITY OF BIOLOGISTS STUDYING THE CELL, THE FUNDAMENTAL UNIT OF LIFE. WE ARE DEDICATED TO ADVANCING SCIENTIFIC DISCOVERY, ADVOCATING SOUND RESEARCH POLICIES, IMPROVING EDUCATION, PROMOTING PROFESSIONAL DEVELOPMENT, AND INCREASING DIVERSITY AND INCLUSIVITY IN THE SCIENTIFIC WORKFORCE.

Non-Profit Donations & Grants

Learn how non-profit organizations benefit from RelSci

$1,000 +

2014

The American Society for Cell Biology

ASCB IS AN INCLUSIVE, INTERNATIONAL COMMUNITY OF BIOLOGISTS STUDYING THE CELL, THE FUNDAMENTAL UNIT OF LIFE. WE ARE DEDICATED TO ADVANCING SCIENTIFIC DISCOVERY, ADVOCATING SOUND RESEARCH POLICIES, IMPROVING EDUCATION, PROMOTING PROFESSIONAL DEVELOPMENT, AND INCREASING DIVERSITY AND INCLUSIVITY IN THE SCIENTIFIC WORKFORCE.

Investments

Details Hidden

Cytokinetics, Inc.

Cytokinetics, Inc. operates as a biopharmaceutical company, which focuses on the discovery and development of muscle activators as potential treatment for debilitating diseases. It conducts a Phase 2 clinical trials program for tirasemtiv, including a Phase 2b clinical trial in patients with ALS, known as BENEFIT-ALS (Blinded Evaluation of Neuromuscular Effects and Functional Improvement with Tirasemtiv in ALS). The company was founded on August 5, 1997 and is headquartered in South San Francisco, CA.

Other Affiliations

James H. Sabry is affiliated with F. Hoffmann-La Roche Ltd., Roche Holding AG, Cytokinetics, Inc., University of California - San Francisco, Arête Therapeutics, Inc., Genentech, Inc., Harvard University - Harvard Medical School, The World Economic Forum, Mayfield Fund LLC, Harvard University - Institute of Politics at John F. Kennedy School of Government, Chugai Pharmaceutical Co., Ltd., F. Hoffmann-La Roche Ltd., California Biomedical Innovation Alliance, Cytokinetics, Inc., HopeLab Foundation, Inc., California Life Sciences Association, The American Society for Cell Biology

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 12 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 12 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by James H. Sabry. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of James H. Sabry's profile does not indicate a business or promotional relationship of any kind between RelSci and James H. Sabry.